AbbVie sees 37% drop in Humira sales this year as biosimilars hit U.S. market
Feb 9 (Reuters) - AbbVie Inc (ABBV.N) stated on Thursday it expects…
AbbVie’s Humira gets a U.S. rival, but costs could stay high
Jan 31 (Reuters) - U.S. sufferers will lastly get entry to cheaper…
